Urte Gayko - Jan 3, 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Urte Gayko
Stock symbol
SMMT
Transactions as of
Jan 3, 2022
Transactions value $
$48,085
Form type
4
Date filed
1/5/2022, 03:07 PM
Previous filing
Nov 16, 2021
Next filing
Apr 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +25K 25K Jan 3, 2022 Common Stock 25K $2.82 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award $48.1K +42.6K +170.21% $1.13 67.6K Jan 3, 2022 Common Stock 42.6K $2.82 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
F2 Not applicable.
F3 The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
F4 The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000.